Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population
NEW YORK, June 24, 2025 /PRNewswire/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ALS, Alzheimer's Disease (AD) and Parkinson's...
Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations
SHANGHAI, June 19, 2025 /PRNewswire/ -- Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety of sunvozertinib versus platinum-based...
Bai Capital Brings U.S. Green Card Solutions to Vietnamese Families at EB-5 Event in Hanoi
Over 30 investors attended the private seminar organized by BAI Capital Vietnam, unlocking pathways to U.S. Green Cards and access to the U.S. public university system. HANOI, Vietnam, June 17, 2025 /PRNewswire/ -- On June 7, BAI Capital hosted the...
Enertis Applus+ Study: LONGi BC Modules Outperform TOPCon in LCOE, Driving Higher Commercial Value
SEVILLE, Spain, June 10, 2025 /PRNewswire/ -- Global technical engineering consultancy Enertis Applus+ has released a comprehensive analysis of a 47MW single-axis tracker PV project in Seville, Spain, comparing the commercial performance of...
The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC
CHENGDU, China, June 7, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating sacituzumab tirumotecan (sac-TMT)...